GNH USA

Europe — EMA

Injexate

GNH USA supplies Injexate (Methotrexate), a DMARD for rheumatoid arthritis, psoriasis and cancers, administered by injection.

Methotrexate

Request sourcing

1
Pack/s

What is Methotrexate?

Methotrexate, the active ingredient in Injexate, is an antimetabolite presented as a sterile solution for subcutaneous injection. It is used to modify disease activity in rheumatoid arthritis, manage severe psoriasis, and as part of chemotherapy regimens for acute lymphoblastic leukemia and osteosarcoma, as well as for medical management of ectopic pregnancy.

GNH USA supplies Injexate as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to EU quality standards and providing regulatory documentation for global distribution.

What is Methotrexate used for?

Methotrexate is a disease‑modifying antirheumatic drug (DMARD) that interferes with folate metabolism in proliferating cells. - Rheumatoid arthritis: reduces joint inflammation and slows structural damage. - Psoriasis: improves skin lesions and decreases disease severity. - Acute lymphoblastic leukemia: part of chemotherapy protocols to inhibit malignant cell proliferation. - Osteosarcoma: used in combination regimens to target rapidly dividing tumor cells. - Ectopic pregnancy: medically terminates non‑viable implantation by preventing trophoblastic growth.

What are the side effects of Methotrexate?

Methotrexate may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Fatigue: persistent tiredness. - Oral ulcers: painful sores in the mouth. - Elevated liver enzymes: mild hepatic irritation. - Cytopenias: reduced white blood cells or platelets.

Serious or Rare Side Effects: - Severe liver toxicity: risk of hepatitis or fibrosis. - Pulmonary fibrosis: progressive lung scarring. - Life‑threatening infections: due to immunosuppression. - Bone marrow aplasia: profound suppression of blood cell production. - Renal failure: impaired kidney function.

What precautions apply to Methotrexate?

When using Methotrexate, several precautions should be observed to minimize risks. - Pregnancy contraindication: avoid use in pregnancy due to teratogenicity (Category X). - Liver monitoring: perform regular liver function tests. - Hematologic monitoring: check complete blood counts frequently. - Renal function: adjust dose or avoid in severe renal impairment. - Concomitant infections: postpone therapy during active infections. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Methotrexate interact with?

Methotrexate interacts with several medicines; awareness of these interactions helps prevent toxicity.

Major Interactions (Avoid): - NSAIDs: increase methotrexate plasma levels and risk of renal toxicity. - Penicillins (e.g., ampicillin): reduce renal clearance, raising toxicity risk. - Sulfonamides: compete for renal tubular secretion, elevating methotrexate concentrations. - Live vaccines: heightened risk of severe infection due to immunosuppression. - Proton pump inhibitors: may increase methotrexate exposure.

Moderate Interactions (Monitor Closely): - Azathioprine: additive bone marrow suppression. - Leflunomide: combined hepatotoxic potential. - Warfarin: may enhance anticoagulant effect. - Oral contraceptives: possible reduced efficacy. - Allopurinol: may increase methotrexate toxicity.

Frequently asked questions

What conditions is Injexate used to treat?+
Injexate contains methotrexate, which is prescribed for several serious conditions. It is commonly used to control rheumatoid arthritis and severe psoriasis, and it forms part of chemotherapy protocols for acute lymphoblastic leukemia and osteosarcoma. It is also employed in the medical management of ectopic pregnancy. Treatment decisions are made by a qualified healthcare professional based on individual disease characteristics.
How does methotrexate work in the body?+
Methotrexate blocks the enzyme dihydrofolate reductase, stopping the formation of tetrahydrofolate needed for DNA and RNA synthesis. By limiting nucleic‑acid production, the drug reduces the proliferation of rapidly dividing cells such as immune cells and cancer cells. This anti‑proliferative and immunosuppressive action underlies its effectiveness in autoimmune diseases and certain malignancies.
What is the usual dose of Injexate?+
The dose of Injexate is individualized by the prescribing physician according to the specific indication, patient weight, renal function, and response to therapy. Healthcare providers calculate the appropriate amount and frequency, which may range from low weekly doses for rheumatic disease to higher, regimented doses in oncology protocols. Patients should follow the exact regimen given by their clinician.
Is Injexate safe to use during pregnancy or while breastfeeding?+
Injexate is classified as Pregnancy Category X because it is known to cause fetal harm and birth defects. It must not be used by pregnant women or women who could become pregnant. Limited data are available for breastfeeding, and the drug is generally contraindicated because it can be excreted in milk and affect the infant. Alternative therapies should be considered.
How do I order Injexate from GNH USA?+
To request Injexate, visit the product page on gnh-usa.com, enter the desired quantity, and submit the enquiry form. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details—including cold‑chain handling if required—and assistance with import documentation.
How does Injexate compare with other disease‑modifying antirheumatic drugs?+
Compared with other DMARDs such as leflunomide or biologic agents, methotrexate (Injexate) is often used as a first‑line oral or injectable therapy because of its long‑track record, cost‑effectiveness, and broad efficacy. Unlike biologics, it is not a protein‑based agent, so it does not require infusion centers, but it does need regular laboratory monitoring for liver and blood‑cell effects.
What are the recommended storage conditions for Injexate?+
Injexate should be stored in a refrigerator at 2 °C to 8 °C. Keep the vial in its original packaging, protect it from light, and do not freeze or shake the solution. If a temporary temperature excursion occurs, consult the product’s stability guidelines before use.
How is Injexate administered to patients?+
Injexate is supplied as a sterile solution for subcutaneous injection. A healthcare professional or trained patient can inject the prescribed dose into the fatty tissue of the abdomen or thigh using an appropriate needle. The injection site should be rotated to reduce local irritation, and aseptic technique must be followed.
What are the most serious risks associated with Injexate therapy?+
The most critical risks include severe liver injury, pulmonary fibrosis, and profound bone‑marrow suppression that can lead to life‑threatening infections or bleeding. Renal toxicity and rare hypersensitivity reactions are also possible. Patients should be monitored regularly for liver enzymes, lung symptoms, blood counts, and kidney function to detect problems early.
Who should not use Injexate?+
Injexate is contraindicated in pregnant women, individuals with known hypersensitivity to methotrexate, patients with severe hepatic or renal impairment, and those with active, uncontrolled infections. Caution is also advised for patients with pre‑existing lung disease or a history of bone‑marrow disorders. Clinicians must evaluate each patient’s medical history before initiating therapy.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Methotrexate
Route
Subcutaneous Use
Manufacturer
Accord Healthcare Polska Sp. Z O.O.
Origin
EU

Related products

A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU